Global D-Dimer Testing Market To Be Driven By Rise In Demand For Coagulation Tests

Today, medical devices field seeks to provide improved health care by focusing on the use of in vitro diagnostic tools. These tools assist in screening, diagnosis, staging as well as disease management for selection of drugs and dosage. D-dimer test is used as a screening test to diagnose thrombosis and consequently rule out conditions of deep vein thrombosis (DVT), pulmonary embolism (PE) and/or disseminated intravascular coagulation (DIC). D-dimer tests avoid unnecessary imaging procedures and treatment and reduce hospital stays. The test avoids risks associated with invasive procedures. The prominent drivers of D-dimer tests include non-invasiveness, device compactness and elimination of radiological intervention.

Transparency Market Research has announced that it has published a new market research report on the global D-dime testing market. The report is titled “D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022” and is available on the company website for sale.The report states that the market will expand at a 2.6% CAGR between 2014 and 2022. The market’s valuation is expected to rise from US$1.5 bn in 2013 to US$1.9 bn in 2022.

Obtain Report Details @ http://www.transparencymarketresearch.com/d-dimer-market.html

D-dimer tests have seen a significant demand rise in the past few years owing to their cost effectiveness, lack of radiological intervention, and accuracy. The continuous rise in the number of patients needing coagulating testing, the introduction of more specific and highly sensitive markers of hemostasis on automated instruments, and assistance of D-dimer tests in monitoring the progress of anti-coagulation therapies in patients with conditions such as pulmonary embolism (PE), deep venous thrombosis (DVT), or disseminated intravascular coagulation (DIC) have helped the global D-dimer testing market.

The report segments the global D-dimer tests market on the basis of three criteria: testing method, application, and geography.

On the basis of testing method, the market has been segmented into point-of-care tests and laboratory tests. Of these, laboratory testing is more preferred owing to its higher accuracy and capability of identifying the chances of an individual having a recurring venous thromboembolism (VTE). The segment of laboratory tests has been further segmented into coagulation analyzers and clinical chemistry analyzers. Of the two major segments of laboratory-based D-dimer testing, the segment of clinical chemistry analyzers sees enjoys higher demand owing to its low cost.

On the basis of application, the D-dimer test market has been segmented into pulmonary embolism, deep venous thrombosis, and disseminated intravascular coagulation (DIC). In 2013, nearly 130 mn D-dimer tests were undertaken for DVT across the globe and the number is expected to rise to 171 mn by 2022. The demand for D-dimer tests is also expected to significantly rise for PE, which is difficult to detect with the help of clinical symptoms alone.

On the basis of geography, the market has been segmented into Asia Pacific, North America, Latin America, Europe, the Middle East and North Africa, and Rest of the World (RoW).

The report also presents a detailed overview of the competitive landscape of the global D-dimer testing market with the help of business profiles, SWOT analysis, finance-related details, and business strategies of some of the key vendors in the market, recent developments, and other data.

Fill The Form To Gain Deeper Insights On This Market @http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2398

The report states that the global D-dimer testing market is highly fragmented in terms of vendors providing reagents, test kits, and instruments. Companies included in the report include Abbott Laboratories, Corgenix, Beckman Coulter, Inc., Trinity Biotech, Alere, Inc., Helena Biosciences, Bio/Data Corporation, F. Hoffman-La Roche Ltd., Dickinson and Company, Becton, Thermo Fisher Scientific, Sysmex Corporation, and Siemens Healthcare.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.